Impact of Racial and Ethnic Disparities on Patients With Dilated Cardiomyopathy JACC Focus Seminar 7/9

Significant race- and ethnicity-based disparities among those diagnosed with dilated cardiomyopathy (DCM) exist and are deeply rooted in the history of many societies. The role of social determinants of racial disparities, including racism and bias, is often overlooked in cardiology. DCM incidence is higher in Black subjects; survival and other outcome measures are worse in Black patients with DCM, with fewer referrals for transplantation. DCM in Black patients is underrecognized and under-referred for effective therapies, a consequence of a complex interplay of social and socioeconomic factors. Strategies to manage social determinants of health must be multifaceted and consider changes in policy to expand access to equitable care; provision of insurance, education, and housing; and addressing racism and bias in health care workers. There is an urgent need to prioritize a social justice approach to health care and the pursuit of health equity to eliminate race and other disparities in the management of cardiovascular disease. (C) 2021 by the American College of Cardiology Foundation.

Automated summary

Race- and ethnicity-based disparities in the diagnosis and treatment of dilated cardiomyopathy are deeply rooted in history and must be addressed through multifaceted strategies and policy changes to ensure health equity.